AbbVie
ABBV
ABBV
2,404 hedge funds and large institutions have $121B invested in AbbVie in 2020 Q2 according to their latest regulatory filings, with 262 funds opening new positions, 1,281 increasing their positions, 672 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
8% more funds holding
Funds holding: 2,221 → 2,404 (+183)
3.83% less ownership
Funds ownership: 73.7% → 69.87% (-3.8%)
13% less call options, than puts
Call options by funds: $1.85B | Put options by funds: $2.12B
Holders
2,404
Holding in Top 10
197
Calls
$1.85B
Puts
$2.12B
Top Buyers
| 1 | +$2.16B | |
| 2 | +$2.14B | |
| 3 | +$1.13B | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$683M |
| 5 |
JPMorgan Chase & Co
New York
|
+$610M |
Top Sellers
| 1 | -$562M | |
| 2 | -$357M | |
| 3 | -$307M | |
| 4 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
-$294M |
| 5 |
Citigroup
New York
|
-$240M |